CytoSorbents Corp. (CTSO)
0.635
+0.01
(+2.39%)
USD |
NASDAQ |
Feb 12, 16:00
CytoSorbents Free Cash Flow : -10.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Delcath Systems, Inc. | 12.04M |
| Quest Diagnostics, Inc. | 1.359B |
| Danaher Corp. | 5.246B |
| Cardiac Biotech Solutions, Inc. | -- |
| Odyssey Health, Inc. | -0.3829M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.577M |
| Cash from Investing (Quarterly) | 0.055M |
| Free Cash Flow Per Share (Quarterly) | -0.0402 |
| Free Cash Flow to Equity (Quarterly) | -2.596M |
| Free Cash Flow to Firm (Quarterly) | -1.949M |
| Free Cash Flow Yield | -26.04% |